Doss MK

Department of Psychiatry and Behavioral Sciences, The University of Texas at Austin Dell Medical School, Austin, TX, USA.

20 papers · 1 preprint · ORCID

ArticlePsilocybin

Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology.

McGovern H, Wellman N, Hutchinson B +4

Europe PMC2026
ArticlePsilocybin

Characterizing Psychedelic-Evoked Familiarity: A Comparative Study with Autobiographical and Déjà Vu Experiences.

Lawrence DW, Doss MK, O'Connor AR

Europe PMC2026
ArticlePsychedelics

Psychedelics do not always enhance cognitive flexibility: The potential role of time-varying effects on reward learning processes.

Kosted R, Doss MK, Donegan JJ +2

Europe PMC2026
ArticlePsychedelics

A critical review of brain entropy as a biomarker of the psychedelic state.

Moses B, Doss MK, Tagliazucchi E

Europe PMC2026
ArticlePsilocybin

An international mega-analysis of psychedelic drug effects on brain circuit function.

Girn M, Doss MK, Roseman L +24

Europe PMC2026
ArticlePsilocybin

Questioning the recovery of dissociated traumatic memories under psilocybin: comment on "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa".

Kangaslampi S, Wolff M, Doss MK +2

Europe PMC2025
ArticlePsilocybin

There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.

Fonzo GA, Doss MK, Nemeroff CB

Europe PMC2025
ArticleAyahuasca

Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study.

Doss MK, Kloft L, Mason NL +6

Europe PMC2025
ArticlePsychedelics

An Integrated theory of false insights and beliefs under psychedelics.

McGovern HT, Grimmer HJ, Doss MK +5

Europe PMC2024
ArticlePsilocybin

Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.

Doss MK, Mallaroni P, Mason NL +1

Europe PMC2024
ArticlePsychedelics

The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?

Barksdale BR, Doss MK, Fonzo GA +1

Europe PMC2024
ArticlePsychedelics

Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics.

Tiwari P, Berghella AP, Sayalı C +3

Europe PMC2023
ArticleMDMA

The acute effects of psychoactive drugs on emotional episodic memory encoding, consolidation, and retrieval: A comprehensive review.

Doss MK, de Wit H, Gallo DA

Europe PMC2023
ArticlePsilocybin

Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.

Doss MK, Barrett FS, Corlett PR

Europe PMC2022
PreprintPsilocybin

Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory

Doss MK, Samaha J, Barrett FS +4

Europe PMC2022
ArticlePsilocybin

Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.

McCulloch DE, Knudsen GM, Barrett FS +10

Europe PMC2022
ArticlePsilocybin

Models of psychedelic drug action: modulation of cortical-subcortical circuits.

Doss MK, Madden MB, Gaddis A +4

Europe PMC2022
ArticlePsilocybin

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.

Doss MK, Považan M, Rosenberg MD +8

Europe PMC2021
ArticlePsilocybin

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.

Yaden DB, Johnson MW, Griffiths RR +6

Europe PMC2021
ArticlePsychedelics

The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain.

Doss MK, May DG, Johnson MW +5

Europe PMC2020
ArticlePsilocybin

Emotions and brain function are altered up to one month after a single high dose of psilocybin.

Barrett FS, Doss MK, Sepeda ND +2

Europe PMC2020